Shandong Sanyuan Biotechnology Co., Ltd
Announcement of IPO results and listing on GEM
Sponsor (lead underwriter): China Securities Co.Ltd(601066)
hot tip
The application of Shandong Sanyuan Biotechnology Co., Ltd. (hereinafter referred to as “Sanyuan biotechnology” or “issuer”) for initial public offering of no more than 33721000 ordinary shares (A shares) (hereinafter referred to as “this offering”) has been examined and approved by the members of the GEM Listing Committee of Shenzhen Stock exchange (hereinafter referred to as “Shenzhen Stock Exchange”), It has been approved for registration by the China Securities Regulatory Commission (zjxk [2021] No. 4073). The sponsor (lead underwriter) of this offering is China Securities Co.Ltd(601066) (hereinafter referred to as ” China Securities Co.Ltd(601066) securities” or “sponsor (lead underwriter)”). The issuer’s shares are referred to as “Sanyuan biology” for short, and the stock code is “301206”.
The issuer negotiated with the recommendation institution (lead underwriter) and determined that the price of this stock issue is 109.30 yuan / share, and the number of shares issued is 33721000. All of them are new shares without the transfer of old shares. The issuing price of this offering shall not exceed the median and weighted average of offline investors’ quotation after excluding the highest quotation, as well as the securities investment fund, national social security fund, basic old-age insurance fund established through public offering after excluding the highest quotation The enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund quotation median and weighted average in accordance with the measures for the administration of the use of insurance funds, whichever is lower. This offering does not arrange strategic placement to other external investors. According to the issuing price, the relevant subsidiaries of the sponsor will not participate in the strategic placement. Finally, this issuance will not be targeted to strategic investors. The difference between the initial strategic placement and the final strategic placement was 1686050 shares, which were transferred back to offline issuance.
This issuance is finally carried out by the combination of offline inquiry and placement to qualified offline investors (hereinafter referred to as “offline issuance”) and online pricing issuance to social public investors holding non restricted A-Shares and non restricted depositary receipts market value in Shenzhen market (hereinafter referred to as “online issuance”).
After the strategic placement call back and before the online and offline call back mechanism was launched, the initial number of offline shares was 24111000, accounting for 71.50% of the number of shares issued this time; The initial number of shares issued online was 9.61 million, accounting for 28.50% of the number issued this time. According to the callback mechanism announced in the announcement of Shandong Sanyuan Biotechnology Co., Ltd. initial public offering and listing on the gem, the issuer and the sponsor (lead underwriter) decided to start the callback mechanism because the initial effective online subscription multiple was 8926.65546 times, higher than 100 times, 20.00% (i.e. 6744500 shares) of this public offering will be transferred back from offline to online. After the callback mechanism was launched, the final number of offline shares issued was 17.3665 million, accounting for 51.50% of the number issued this time; The final number of shares issued online was 16354500, accounting for 48.50% of the number issued this time. After the callback mechanism was launched, the final winning rate of online issuance was 0.0190644864%, and the effective subscription multiple was 5245.35504 times.
The online and offline subscription and payment work of this offering has been completed on January 26, 2022 (T + 2). The details are as follows:
1、 Statistics of new share subscription
According to the data provided by Shenzhen Stock Exchange and Shenzhen Branch of China depository and Clearing Corporation Limited (hereinafter referred to as “Shenzhen Branch of China Clearing”), the sponsor (lead underwriter) made statistics on the subscription of new shares issued online and offline, and the results are as follows:
(I) online subscription of new shares
1. Number of shares subscribed by online investors (shares): 15770953
2. Subscription amount paid by online investors (yuan): 1723765162.90
3. Number of online investors giving up subscription (shares): 583547
4. Subscription amount waived by online investors (yuan): 63781687.10
(II) offline subscription of new shares
1. Number of shares subscribed by offline investors (shares): 17366500
2. Subscription amount paid by offline investors (yuan): 1898158450
3. Number of offline investors giving up subscription (shares): 0
4. Subscription amount abandoned by offline investors (yuan): 0
2、 Offline proportional restriction
The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise that the sales restriction period of 10% (rounded up) of the number of shares allocated to them is 6 months from the date of the issuer’s initial public offering and listing. That is, among the shares allocated to each placing object, 90% of the shares are sold indefinitely and can be circulated from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange; The sales restriction period of 10% of the shares is 6 months, and the sales restriction period starts from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange.
When offline investors participate in the preliminary inquiry and quotation and offline purchase, they do not need to fill in the arrangement of the restricted sale period for the placing objects under their management. Once the quotation is made, it is deemed to accept the arrangement of the online restricted sale period disclosed in this announcement.
The restricted period of 1739471 shares issued offline is 6 months, accounting for about 10.0162% of the total issued offline and 5.1584% of the total issued shares.
3、 Underwriting by the recommendation institution (lead underwriter)
The number of shares abandoned by online and offline investors is underwritten by the sponsor (lead underwriter). The number of shares underwritten by the sponsor (lead underwriter) is 583547, with an underwriting amount of 63781687.10 yuan. The number of shares underwritten by the recommendation institution (lead underwriter) accounts for about 1.73% of the total shares of this public offering.
On January 28, 2022 (T + 4), the recommendation institution (lead underwriter) transferred the underwriting funds and the funds raised from online and offline issuance to the issuer after deducting the recommendation and underwriting fee. The issuer shall submit an application for share registration to CSDCC Shenzhen Branch and register the underwritten shares to the securities account designated by the sponsor (lead underwriter). 4、 Contact information of sponsor (lead underwriter)
If online and offline investors have any questions about the issuance results announced in this announcement, please contact the sponsor (lead underwriter) of this issuance. The specific contact information is as follows:
Sponsor (lead underwriter): China Securities Co.Ltd(601066)
Contact: equity capital market department
Tel: 010-86451545, 86451546
Issuer: sponsor (lead underwriter) of Shandong Sanyuan Biotechnology Co., Ltd.: China Securities Co.Ltd(601066) January 28, 2022 (there is no text on this page, which is the cover page of the announcement on the results of initial public offering and listing on the gem of Shandong Sanyuan Biotechnology Co., Ltd.)
Issuer: Shandong Sanyuan Biotechnology Co., Ltd. (this page has no text and is the seal page of the announcement on the results of initial public offering and listing on the gem of Shandong Sanyuan Biotechnology Co., Ltd.)
Sponsor (lead underwriter): China Securities Co.Ltd(601066) mm / DD / yy
